William Blair & Company
FSTX

William Blair & Company’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

William Blair & Company’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,431
Closed -$144K – 1785
2019
Q1 		$144K Buy
3,431
+262
+8% +$11K ﹤0.01% 1354
2018
Q4 		$132K Buy
3,169
+613
+24% +$27.6K ﹤0.01% 1286
2018
Q3 		$123K Buy
+2,556
New +$128K ﹤0.01% 1361
2018
Q1 		– Sell
-11,517
Closed -$619K – 1609
2017
Q4 		$619K Buy
11,517
+2,298
+25% +$137K ﹤0.01% 894
2017
Q3 		$621K Buy
+9,219
New +$528K ﹤0.01% 863

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company's FSTX Position: Q2 2019 in Review

William Blair & Company sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 3,431 shares — an estimated $144K sold.

William Blair & Company first reported a position in FSTX in Q3 2017 and held it in 5 quarters. The position peaked at $621K in Q3 2017. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • William Blair & Company reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • William Blair & Company sold 3,431 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $144K.
  • William Blair & Company first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
  • William Blair & Company's F-star Therapeutics, Inc. Common Stock position peaked at $621K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.